SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Verge Genomics, a clinical-stage, tech-enabled biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform drug ...

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB) New analyses of Phase 2b clinical trial reinforce t ...

Recently validated markers have helped improve treatment but more are needed ...

Massive Bio, a technology company that uses artificial intelligence to help cancer patients identify clinical trials for ...

Source: Getty Images Despite proven benefits, biomarker tests remain underused in clinical practice. By examining genetic markers from urine or tissue samples, biomarkers provide a more precise ...

Cognitive decline in very old adults has been considered for decades to be an almost inevitable consequence of aging. In ...

Spun out from Splash Clinical, SplashBIO brings biomarker pre-screening to the front of the clinical trial - built to reduce screen failures and accelerate enrollment. The newly independent company wi ...

The 15 th World Clinical Biomarkers & Companion Diagnostics Summit Europe, held in London from April 8 th to 10 th, aims to address common concerns among European Biomarker, Translational, and ...

Universal Brain's EEG cap seeks to bring precision into mental health treatment and drug development. With $7.9 million ...